A phase 1 clinical trial was conducted to evaluate the safety and pharmacokinetics of BPC 157 compared to placebo in healthy volunteers, with results reportedly submitted to ClinicalTrials.gov on May 23, 2016
(2021b) Characterization of americium and curium complexes with the protein lanmodulin: a potential macromolecular mechanism for actinide mobility in the environment
Organic Aloe Barbadensis Leaf Juice, Pentylene Glycol, Niacinamide, Hydrolyzed Hyaluronic Acid, GHK-cu (Copper Tripeptide-1), Vitamin B5, CITRUSTEM(Citrus Aurantium Dulcis/Orange Callus Culture Extract, Acetyl Hexapeptide-8, Allantoin, Palmitoyl Tripeptide-5, Palmitoyl Tetrapeptide-7, Centella Aisatica), Methylsulfonylmethane, Glycine, Zinc, Glutathione, Hydrolyzed Quinoa, Spirulina, Lysine, Disodium EDTA, Ethylhexylglycerin
Oxyntomodulin analogue increases energy expenditure via the glucagon receptor